Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013		Jun. 24, 2012
Cash flows from operating activities:
Net loss	$ (19,357)		$ (105,456)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	14,487		16,475
Deferred taxes	(305)		(916)
Stock-based compensation	3,859		2,814
Provision for losses on accounts receivable	(522)		3,296
Excess tax benefit on stock compensation	(122)		(97)
Loss (gain) on disposal of fixed assets	375		(295)
Litigation settlement	(6,584)		0
Intangible impairment	0		672
Goodwill impairment	0		64,807
Gain on sale of subsidiary	(248)		0
Loss on sale of discontinued operations	13,024		0
Restructuring related asset impairment	731		5,297
Decrease (increase) in current assets, net of the effects of acquired companies:
Accounts receivable	41,613		33,961
Inventories	(2,456)		7,357
Other current assets	2,690		(1,198)
Increase (decrease) in current liabilities, net of the effects of acquired companies:
Accounts payable	3,351		(12,117)
Income taxes	(2,329)		(3,325)
Unearned revenues	(7,007)		(9,166)
Restructuring reserve	(5,059)		2,125
Other current and accrued liabilities	(19,182)		6,371
Net cash provided by operating activities	16,959		10,605
Cash flows from investing activities:
Acquisition of property, plant, and equipment and intangibles	(3,310)		(8,383)
Change in restricted cash	0		39
Cash proceeds from the sale of discontinued operations	1,290		0
Cash proceeds from the sale of subsidiary	227		0
Other investing activities	921		518
Net cash used in investing activities	(872)		(7,826)
Cash flows from financing activities:
Proceeds from stock issuances	1,545		623
Excess tax benefit on stock compensation	122		97
Proceeds from short-term debt	2,759		2,863
Payment of short-term debt	(2,561)		(10,765)
Net change in factoring and bank overdrafts	(339)		(1,475)
Proceeds from long-term debt	0		3,000
Payment of long-term debt	(10,113)		(5,380)
Net cash provided used in financing activities	(8,587)		(11,037)
Effect of foreign currency rate fluctuations on cash and cash equivalents	(3,204)		(958)
Net increase (decrease) in cash and cash equivalents	4,296		(9,216)
Cash and cash equivalents:
Beginning of period	118,829	[1]	93,481
End of period	$ 123,125		$ 84,265	[1]

[1] Derived from the Company’s audited Consolidated Financial Statements at December 30, 2012.